However, while translocations involving the MECOM locus are only found in around 2.5% of AML patients, EVI1 overexpression can be detected in around 10% of all AMLs and for many patients, the mechanism behind this is not clear. This evidence concerns the gene MECOM and acute myeloid leukemia.